RBR-33ndb47招募中不适用
Evaluation of the humoral response to the ChAdOx1-nCov19 (AstraZeneca-Oxford/Fiocruz) and Coronavac (Butantan) vaccines against COVID-19 in Brazil: a prospective and retrospective cohort
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18Y 至 0（—）
入选标准
- •Men and women aged 18 years and over; A resident of the metropolitan region of Rio de Janeiro or the state of Ceará; Have received at least one dose of ChAdOx1-nCov19 (AstraZeneca-Oxford /Fiocruz) or Coronavac (Butantan) vaccine in the states of Rio de Janeiro or Ceará; Accept to participate in the study by signing the Informed Consent Form.
排除标准
- •Men and women with unavailability to comply with the follow-up schedule
研究者
相似试验
招募中
2 期
Immune response of booster dose with ChAdOx-1 in adult who had received 2 doses of CoronaVac (COVID-19)Prevention of COVID-19 with booster-dose strategy among healthy adult who received 2-dose of Coronavac using ChAdOx1 nCoV-19 vaccine.COVID-19 Vaccine, AstraZeneca Booster , Fractional low dose vaccineTCTR20210722003Health and Aging Platform, Chulalongkorn University400
招募中
不适用
Comparison of the Immunogenicity of ChAdOx1 nCoV-19 (COVID-19) Vaccine against the Wild-Type and Delta Variant in Hemodialysis Patients and Healthy VolunteersImmune response after ChAdOx1 nCoV-19 Vaccine in hemodialysis patients compared to healthy volunteers.Immune response, ChAdOx1 nCoV-19 Vaccine, Hemodialysis patients, wild-type, delta variant, antibody, T-cell responseTCTR20211026002Kao Tun Roke Foundation130
招募中
不适用
Comparison of the Immunogenicity of ChAdOx1 nCoV-19 (COVID-19) Vaccine against the Wild-Type and Delta Variant in Kidney Transplant Recipients and Healthy VolunteersImmune response after ChAdOx1 nCoV-19 Vaccine in kidney transplant patients compared to healthy volunteers.Immune response, ChAdOx1 nCoV-19 Vaccine, kidney transplant patients, Wuhan Strain, B.1.617.2 (Delta) Variant, antibody, T-cell responseTCTR20211025004Kao Tun Roke Foundation200
已完成
4 期
Immunogenicity and safety of ChAdOx1 vaccine (Covid-19 vaccine) in Thai people with underlying diseaseDiabetes mellitusCirrhosissolid cancerHematologic malignancychronic kidney diseaserheumatological diseasecardiovascular diseaseChAdOx1 vaccineimmunogenicitycovid-19 vaccineTCTR20211228003Chulabhorn Royal Academy385
招募中
不适用
To determine the safety and antibody performance in Indian adults after taking COVID-19 vaccine.CTRI/2021/03/031998Advanced Cancer for Treatment Research and Education in cancer and Tata Memorial Centre